论文部分内容阅读
目的 探讨经皮肝胆道内支架置入治疗恶性梗阻性黄疸的疗效及并发症。方法 对 32例恶性梗阻性黄疸患者经皮肝穿胆道内行支架置入术 ,其中 2 8例为内涵管 ,4例为金属内支架。随访 35～ 376天 ,观察近中期疗效和并发症。结果 经皮肝胆道内支架置入术技术成功率为 10 0 %。置入术后 1周血总胆红素水平较置入前明显下降 (P<0 .0 0 1)。开通时间平均为 10 1天 ,半年开通率为 5 6 .2 5 %。并发症发生率 2 4.98% ,为主要包括胰腺炎和逆行胆道感染等。结论 经皮肝胆道内架置入术疗效可靠 ,是一种安全 ,可作为恶性胆管阻塞介入治疗的一种姑息性疗法。
Objective To investigate the efficacy and complications of percutaneous transhepatic biliary stenting in the treatment of malignant obstructive jaundice. Methods Percutaneous transhepatic biliary stenting was performed in 32 patients with malignant obstructive jaundice, of which 28 were endoscopic tubes and 4 were metal stent. Follow-up 35 ~ 376 days, observed near and mid-term efficacy and complications. Results The success rate of percutaneous transhepatic biliary stent implantation was 100%. The level of total bilirubin was significantly decreased 1 week after operation (P <0.01). The opening time averaged 10 days and the half-year opening rate was 56.25%. The complication rate was 2. 4.98%, mainly including pancreatitis and retrograde biliary tract infection. Conclusion Percutaneous transhepatic biliary stent placement is reliable and safe. It can be used as a palliative therapy for the interventional treatment of malignant biliary obstruction.